nach oben

Drug Safety

Erschienen in:

01.09.2010 | Correspondence

Statins and Muscle Adverse Effects

A Complementary Perspective

verfasst von: Beatrice A. Golomb, Sabrina Koperski, Marcella A. Evans

Erschienen in: Drug Safety | Ausgabe 9/2010

Einloggen, um Zugang zu erhalten

Excerpt

We appreciate the article by Chatzizisis et al.,[1] which focused on risk factors and drug interactions as they relate to HMG-CoA reductase inhibitor (‘statin’) muscle adverse effects. We would like to direct readers to our review article on statin adverse effects:[2] tables I, II and IV, and III of our paper (respectively) parallel table I, figure I and table III of the Chatzizisis et al. paper. These address reported types of muscle adverse effects, adverse effect risk factors and drug interactions, in many cases complementing and/or supplementing findings provided by Chatzizisis et al., and also placing the findings in a theoretical framework. …

Chatzizisis YS, Koskinas KC, Misirli G, et al. Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment. Drug Saf 2010; 33: 171–87PubMedCrossRef

Golomb BA, Evans MA. Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism. Am J Cardiovasc Drugs 2008; 8: 373–418PubMedCrossRef

Venero CV, Venero JV, Wortham DC, et al. Lipid-lowering efficacy of red yeast rice in a population intolerant to statins. Am J Cardiol 2010; 105: 664–6PubMedCrossRef

Tsukahara M, Shinzato N, Tamaki Y, et al. Red yeast rice fermentation by selected Monascus sp. with deep-red color, lovastatin production but no citrinin, and effect of temperature-shift cultivation on lovastatin production. Appl Biochem Biotechnol 2009; 158: 476–82PubMedCrossRef

Smith DJ, Olive KE. Chinese red rice-induced myopathy. South Med J 2003; 96: 1265–7PubMedCrossRef

Prasad GV, Wong T, Meliton G, et al. Rhabdomyolysis due to red yeast rice (Monascus purpureus) in a renal transplant recipient. Transplantation 2002; 74: 1200–1PubMedCrossRef

Titel: Statins and Muscle Adverse Effects
A Complementary Perspective
verfasst von: Beatrice A. Golomb
Sabrina Koperski
Marcella A. Evans
Publikationsdatum: 01.09.2010
Verlag: Springer International Publishing
Erschienen in: Drug Safety / Ausgabe 9/2010
Print ISSN: 0114-5916
Elektronische ISSN: 1179-1942
DOI: https://doi.org/10.2165/11538820-000000000-00000

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Statins and Muscle Adverse Effects

A Complementary Perspective

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2010

Lactic Acidosis Induced by Metformin

Angiotensin Receptor Blockers and the Risk of Malignancy

Medications and Glucose-6-Phosphate Dehydrogenase Deficiency

The Authors’ Reply

Identifying Major Congenital Malformations in the UK General Practice Research Database (GPRD)

Safety Profile of the Fluoroquinolones